# clm_EB7DE0743EFE

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 641,800,000 United States dollar  
valid_from: 2019-03-31  
valid_to: 2019-06-30  
published: 2019-05-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1EB9C85348DD  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly research and development: 641,800,000 United States dollar", as of 2019-03-31 (until 2019-06-30). Claim clm_EB7DE0743EFE, https://asof.is/claim/clm_EB7DE0743EFE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2019, filed 2019-05-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217619000017/0001532176-19-000017-index.htm (primary, SEC EDGAR 10-Q Q1 FY2019, published 2019-05-07)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 556,972,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_EB7DE0743EFE](/claim/clm_EB7DE0743EFE.md) | [clm_B522A588AB4A](/claim/clm_B522A588AB4A.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.